Balance Sheet Data

ACADIA Pharmaceuticals Inc. (ACAD)

$24.01

+0.77 (+3.31%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 473.52697.43631.96520.71416.82964.371,201.161,496.091,863.442,320.99
Total Cash (%)
Account Receivables 27.7937.8750.2865.3463.0878.1697.35121.26151.03188.11
Account Receivables (%)
Inventories 4.076.349.687.886.6411.3314.1117.5721.8927.26
Inventories (%)
Accounts Payable 3.177.228.496.8812.7512.0515.0118.6923.2829
Accounts Payable (%)
Capital Expenditure -2.15-1.13-7.59-1.12-4.19-5.22-6.50-8.10-10.09-12.57
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.